Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model  David G. Neschis,

Slides:



Advertisements
Similar presentations
Human adult endothelial cell growth in culture
Advertisements

Natural history, duplex characteristics, and histopathologic correlation of arterial injuries in a canine model  Thomas F. Panetta, MD, Clifford M. Sales,
The Role of ex-vivo Gene Therapy of Vein Grafts with Egr-1 Decoy in the Suppression of Intimal Hyperplasia  M. Peroulis, J. Kakisis, A. Kapelouzou, A.
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin  Todd K. Rosengart, MD, Kurt.
Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide  Yue Li, Lucinda.
Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-α and interleukin-6, but accentuates.
Robert J. Pitsch, MD, David J. Minion, MD, Margaret L
Dose responsive suppression of myointimal hyperplasia by dexamethasone
James W. Dennis, MD, Eric R. Frykberg, MD, FACS, John M
Lysyl oxidase expression in a rat model of arterial balloon injury
Randolph L. Geary, MD, Seppo T. Nikkari, MD, William D. Wagner, PhD, J
Persistent sciatic artery and vein: An unusual case
Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts  Abigail K. Hanna,
Does compliance mismatch alone cause neointimal hyperplasia?
Hemagglutinating virus of Japan-liposome–mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein.
Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model  Jian-Ming Li, MD, Mohammad.
The differential effect of contrast agents on endothelial cell and smooth muscle cell growth in vitro  Carol J. Sawmiller, MD, Richard J. Powell, MD,
Mark Wengrovitz, MD. , Lulseged G. Selassie, MD. , Robert R. M
Overexpression of mutated IκBα inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation  Brian S Zuckerbraun, MD, Carol A.
Vida K. Stark, MS, Thomas F. Warner, MD, John R. Hoch, MD 
Thomas E. Arnold, MD, Dmitri Gnatenko, PhD, Wadie F. Bahou, MD 
Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA*  Eric T. Choi, MD, Leslie Engel, PhD, Allan.
Percutaneous transplantation of genetically-modified autologous fibroblasts in the rabbit femoral artery: a novel approach for cardiovascular gene therapy 
Howard P. Greisler, MD, Joan Ellinger, Scott C. Henderson, Anne M
Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury  Jian-ming Li, MD, Michael J Singh, MD, Mazen Itani, MD,
Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide  Kathleen G. Raman, MD, Joel E. Barbato, MD, Emeka Ifedigbo,
Fogarty and percutaneous transluminal coronary angioplasty balloon injury induce comparable damage to the arterial wall but lead to different healing.
Magnetic nanosphere-guided site-specific delivery of vascular endothelial growth factor gene attenuates restenosis in rabbit balloon-injured artery  Tiemin.
S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo  Yih-Jer Wu, MD, PhD, Graciela.
Improved retroviral transduction efficiency of vascular cells in vitro and in vivo during clinically relevant incubation periods using centrifugation.
Vincent L. Rowe, MD, Scott L. Stevens, MD, FACS, Tonya T
Reduction of myointimal hyperplasia after arterial anastomosis by local injection of transforming growth factor β3  Jonathan Ghosh, MD, MRCS, Mohammed.
Malcolm O. Perry, MD, Richard Kempczinski, MD 
Conformational stress and anastomotic hyperplasia
William W. Lin, BA, Gregory S. McGee, MD, Bruce K
Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury  Abigail K. Hanna, MD, Jonathan C. Fox, MD,
Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors  Mohammad H. Eslami, MD, Sidhu P. Gangadharan, MD,
A.C. Dang, M.D., A.P. Warren, M.D., H.T. Kim, M.D., Ph.D. 
Differences in reendothelialization after balloon catheter removal of endothelial cells, superficial endarterectomy, and deep endarterectomy  Steven G.
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin  Todd K. Rosengart, MD, Kurt.
Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions  Michael Madigan, MD, Fateh Entabi, MD, Brian Zuckerbraun, MD,
Marcel Scheinman, MD, Enrico Ascher, MD, Gabriel S
Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation 
Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury  Michael C Moon, MD, Katerina Molnar,
Local photodynamic action of methylene blue favorably modulates the postinterventional vascular wound healing response  Joerg Heckenkamp, MD, Farzin Adili,
Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity  Jeffrey M. Rhodes, MD, Jae-Sung Cho, MD, Peter.
Early healing after carotid endarterectomy: Effect of high- and low-dose aspirin on thrombosis and early neointimal hyperplasia in a nonhuman primate.
Antisense basic fibroblast growth factor alters the time course of mitogen-activated protein kinase in arterialized vein graft remodeling  Akimasa Yamashita,
The effects of low-dose radiation on neointimal hyperplasia
Mark K. Hirko, MD, Joseph R. McShannic, MD, Steven P
Robert A. McCready, M. D. , Margaret A. Price, B. S. , Richard J
Yehuda G. Wolf, MD, Lars M. Rasmussen, MD, Yoav Sherman, MD, Warner P
Murray H. Kown, MDa, Atsushi Yamaguchi, MDa, Christina L
Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia  Steven.
Angioscope-assisted occlusion of venous tributaries with prolamine in in situ femoropopliteal bypass: Preliminary results of canine experiments  John.
Boulos Toursarkissian, MD, David Schwartz, MD, PhD, Paul R
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms  David A. Bigatel, MD, James R. Elmore, MD, David.
Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation  Hideki Tatewaki, MD,
Cardiovascular surgery—The rocket and its stars: Presidential address
Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-β1 in healing rat vein grafts  Randal A Wolff, PhD, Jeffrey.
Joseph J. Piotrowski, MD, Glenn C. Hunter, MD, Cleamond D
Sidhu P. Gangadharan, MD, Mohammad H. Eslami, MD, Inanna P
Exposure of femoral vessels by a suprainguinal incision
Glenn C. Hunter, M.D., Stan N. Carson, M.D. 
Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery  Robert A. Larson, MD, Mina.
George D. Lilly 1906–1988 Journal of Vascular Surgery
Volume 3, Issue 1, Pages 8-13 (January 2001)
Innominate artery trauma: A thirty-year experience
Thigh claudication due to profunda femoris artery occlusion
Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—A review  Alexander W. Clowes, MD, Michael A. Reidy,
Presentation transcript:

Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model  David G. Neschis, MD, Shawn D. Safford, MD, Abigail K. Hanna, MD, Jonathan C. Fox, MD, PhD, Michael A. Golden, MD  Journal of Vascular Surgery  Volume 27, Issue 1, Pages 126-134 (January 1998) DOI: 10.1016/S0741-5214(98)70299-X Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 1 A, En face views of luminal surface of multiple discontinuous segments of a single rabbit superficial femoral artery treated with Ad.lacZ at 1 × 1010 pfu/ml via 20 minute local intraluminal incubation and stained with X-gal chromagen 4 days after balloon injury and vector delivery. These images demonstrate successful gene delivery and protein production along the full length of the treated vessel. Note segment in upper left image that demonstrates demarcation between treated and nontreated zones. Original magnification, ×7.5. B, Cross-sectional photomicrograph of a segment of rabbit superficial femoral artery treated with Ad.lacZ at 1 × 1010 pfu/ml via 20 minute local intraluminal incubation and stained with X-gal chromagen 4 days after balloon injury and vector delivery. Segments were then embedded, sectioned, and counterstained with nuclear-fast red. This image demonstrates greater than 90% gene transfer efficiency with gene delivery through the thickness of the media. Original magnification, ×125. Journal of Vascular Surgery 1998 27, 126-134DOI: (10.1016/S0741-5214(98)70299-X) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 2 Hematoxylin and eosin–stained photomicrographs of rabbit superficial femoral arteries 14 days after balloon injury. A, Treated with Ad.lacZ at 1 × 1010 pfu/ml. B, Treated with PBS vehicle alone. C, Treated with Ad.ASbFGF at 1 × 1010 pfu/ml. All treatment solutions were delivered as a local intraluminal incubation for 20 minutes, placed immediately after balloon injury and brief PBS irrigation. These photomicrographs demonstrate a marked inhibition of neointimal thickening in the Ad.ASbFGF-treated vessels. Original magnification, ×125. Journal of Vascular Surgery 1998 27, 126-134DOI: (10.1016/S0741-5214(98)70299-X) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 3 I/M thickness ratios 14 days after balloon injury immediately followed by a 20-minute local incubation of treatment solution. Treatment groups included PBS vehicle alone, Ad.lacZ at 1 × 1010 pfu/ml, and Ad.ASbFGF at 1 × 1010 pfu/ml. Graph demonstrates significant reduction in intimal thickening in Ad.ASbFGF group compared with PBS and Ad.lacZ control groups (p = 0.004 and p < 0.0001, respectively). There was no significant difference in intimal thickening between the PBS and Ad.lacZ groups (p = 0.27). Journal of Vascular Surgery 1998 27, 126-134DOI: (10.1016/S0741-5214(98)70299-X) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 4 Indirect fluorescence microscopy of rabbit superficial femoral artery segments 4 days after balloon injury, treated with either Ad.lacZ at 1 × 1010 pfu/ml or Ad.ASbFGF at 1 × 1010 pfu/ml by local intraluminal incubation immediately after injury. A, C, and E, Red emission demonstrates propidium iodide counterstained nuclei (visualizing all nuclei present) of Ad.lacZ-treated, negative control, and Ad.ASbFGF-treated vessels, respectively. B, D, and F, Green emission visualizes FITC-labeled nuclei of cells undergoing apoptosis of Ad.lacZ-treated, negative control, and Ad.ASbFGF-treated vessels, respectively. Images demonstrate an increase in apoptotic cells in media of Ad.ASbFGF-treated vessel (F) compared with Ad.lacZ-treated vessels or negative control. Negative controls were of an Ad.ASbFGF-treated vessel stained in parallel with other sections but incubated in the absence of terminal deoxynucleotidyl transferase (TdT) enzyme. Original magnification, ×125. Journal of Vascular Surgery 1998 27, 126-134DOI: (10.1016/S0741-5214(98)70299-X) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions